Inventor
Yuzuru Eto
Inventor
Kawasaki, JP
Overview
Patents· 27 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Kprimary
A61KPreparations for medical, dental or toiletry purposes16%
A23LFoods, foodstuffs or non-alcoholic beverages, not otherwise provided for15%
C07KPeptides15%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations12%
G01NInvestigating or analysing materials by determining their chemical or physical properties7%
Y10STechnical subjects covered by former uspc cross-reference art collections [xracs] and digests5%
C07CAcyclic or carbocyclic compounds4%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium4%
C12NMicroorganisms or enzymes4%
A23CDairy products, e.g. milk, butter or cheese3%
PatentTitleYear
9,844,226Use of peptides for imparting kokumi20179,420,813'Sweetener'20169,395,376'Kokumi-imparting agent'20169,222,944'Method for screening a salty taste modulating substance'20159,174,932'CaSR agonists'20159,150,505'Prophylactic or therapeutic agent for diabetes or obesity'20158,877,739'Prophylactic agent or therapeutic agent for diabetes or obesity'20148,796,485'CaSR agonists'20148,568,814'Lanthionine derivatives'20138,541,379'Kokumi-imparting agent'20138,454,978'Immunostimulating agent'20138,420,144'Kokumi-imparting agent, method of using, and compositions containing same'20138,399,417'Food'20138,173,605'Kokumi-imparting agent'20128,106,020'Calcium receptor activator'20127,423,019'Agent for inducing conversion of intestinal cells into insulin-producing cells and antidiabetic drug'20087,375,085'Melanocyte-stimulating hormone inhibitors'20086,872,703'Insulin receptor-related receptor binding protein'20056,756,482'Purified human activin and process for producing the same'20046,084,076'Method of refolding human activin A'20005,948,662'Bacillus-derived transglutaminase'19995,847,078'Polypeptide capable of differentiating and maturing malignant cells into normal cells or capable of accelerating the formulation of erythroblasts'19985,731,183'Bacillus-derived transglutaminase'19985,558,861'Modified microbially-produced cellulose gel with human epidermal cells adsorbed thereon for use as a skin graft or vulnerary cover'19965,525,335'Wound healing agent'19965,240,911'Method of reducing blood sugar levels using a hypoglycemic agent'19935,200,395'Pharmaceutical composition of BUF-5 for treating anemia'1993Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
1993–2017Patents assigned to AJINOMOTO KK (27)· patent assignee history
1993–2017Based in Kawasaki, JP· patent location history
1998–2015Based in Kanagawa, JP· patent location history
2012–2017Patents assigned to ETO YUZURU (13)· patent assignee history
2012–2017Patents assigned to MIYAMURA NAOHIRO (7)· patent assignee history
2012–2016Patents assigned to AMINO YUSUKE (5)· patent assignee history
2012–2016Patents assigned to NAGASAKI HIROAKI (5)· patent assignee history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| AJINOMOTO KK | 27 | 1993–2017 |
| ETO YUZURUself | 13 | 2012–2017 |
| MIYAMURA NAOHIRO | 7 | 2012–2017 |
| AMINO YUSUKE | 5 | 2012–2016 |
| NAGASAKI HIROAKI | 5 | 2012–2016 |
Locations
| Location | Patents | Span |
|---|---|---|
| Kawasaki, JP | 25 | 1993–2017 |
| Kanagawa, JP | 2 | 1998–2015 |